1. 「第55回日本肝臓学会総会 パネルディスカッション5：肝癌診療ガイドライン2017を再検証する」を振り返って
   , 2020, Kanzo CrossRef
2. Efficacy of hepatic arterial infusion chemotherapy and its combination strategies for advanced hepatocellular carcinoma: A network meta-analysis
   Shun-An Zhou et al, 2024, World Journal of Gastrointestinal Oncology CrossRef
3. Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
   Kazuomi Ueshima et al, 2020, Liver Cancer CrossRef
4. Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
   Bingran Yu et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
5. A long-term survival case of advanced hepatocellular carcinoma treated with multidisciplinary therapies with progression to hepatic arterial infusion chemotherapy and hepatectomy
   Hiroyuki Suzuki et al, 2020, Kanzo CrossRef
6. Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review
   Wei Zhang et al, 2023, Frontiers in Oncology CrossRef
7. Clinical Effects and Safety of Intra-Arterial Infusion Chemotherapy with Lipiodol versus Intra-Arterial Infusion Chemotherapy Alone for Treatment of Advanced Hepatocellular Carcinoma
   Su Ho Kim et al, 2024, Oncology CrossRef
8. Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical Trial
   YUICHI GOTO et al, 2021, The Kurume Medical Journal CrossRef